Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Once-daily skin patch for Parkinson's disease and restless legs. | Dopamine agonist for Parkinson's disease and restless legs. |
| Body system | Brain & Nerves | Brain & Nerves |
| Drug class | Dopaminergic medicines | Dopaminergic medicines |
| Supply | Prescription only | Prescription only |
| Main uses | Parkinson's disease, Restless legs syndrome | Parkinson's disease, Restless legs syndrome |
| How it works | Acts like dopamine in the brain, delivered by a patch. | Acts like dopamine in the movement centres of the brain. |
| Starts working | Days | Hours; full effect over weeks |
| Half-life | 5–7 hours after removal | About 6 hours |
| Typical adult dose | 2–8 mg per 24 hours for Parkinson's (up to 16 mg in advanced disease); 1–3 mg per 24 hours for RLS. | 0.25 mg three times a day, increased weekly to 3–9 mg a day (up to 24 mg); RLS 0.25–4 mg once at night. |
| Forms | Transdermal patch | Tablet, Extended-release tablet |
| Common side effects | Skin reactions at the patch site, Nausea, Sleepiness, Dizziness | Nausea, Dizziness on standing, Sleepiness, Swelling of ankles |
| Serious side effects | Sudden sleep onset, Impulse-control disorders, Hallucinations, Low blood pressure | Sudden sleep onset, Compulsive gambling, shopping or eating, Hallucinations, Low blood pressure |
| Don't take if | MRI scanning with the patch on; Severe heart disease (caution) | Severe kidney or liver disease; Psychosis (caution) |
| Alcohol | Best avoided. Alcohol adds to drowsiness. | Best avoided. Alcohol adds to drowsiness and dizziness. |
| Pregnancy | Usually avoidedNot recommended. | Use with cautionLimited data. |
| Breastfeeding | Usually avoidedMay reduce milk. | Usually avoidedMay reduce milk production. |
| In use since | — | — |
| Brand names | United States: NeuproUnited Kingdom: NeuproIndia: Neupro | United States: RequipUnited Kingdom: Requip, AdartrelIndia: Ropark, Ropitor |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | N04BC09 | N04BC04 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker